New Results
IL-32 is a metabolic regulator promoting survival and proliferation of malignant plasma cells
Kristin Roseth Aass, Robin Mjelle, Martin H. Kastnes, Synne S. Tryggestad, Luca M. van den Brink, Marita Westhrin, Muhammad Zahoor, Siv H. Moen, Glenn Buene, Kristine Misund, Anne-Marit Sponaas, Qianli Ma, Anders Sundan, Richard WJ Groen, Tobias S. Slørdahl, Anders Waage, View ORCID ProfileTherese Standal
doi: https://doi.org/10.1101/2021.02.22.431638
Kristin Roseth Aass
1Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway
2Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
Robin Mjelle
2Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
Martin H. Kastnes
1Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway
2Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
Synne S. Tryggestad
1Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway
2Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
Luca M. van den Brink
1Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway
Marita Westhrin
1Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway
Muhammad Zahoor
3Department of Hematology, St.Olavs University Hospital, Trondheim, Norway
Siv H. Moen
1Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway
2Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
Glenn Buene
1Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway
2Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
Kristine Misund
2Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
Anne-Marit Sponaas
2Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
Qianli Ma
1Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway
2Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
Anders Sundan
1Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway
2Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
Richard WJ Groen
5Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands
Tobias S. Slørdahl
2Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
3Department of Hematology, St.Olavs University Hospital, Trondheim, Norway
Anders Waage
2Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
3Department of Hematology, St.Olavs University Hospital, Trondheim, Norway
Therese Standal
1Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway
2Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
3Department of Hematology, St.Olavs University Hospital, Trondheim, Norway
Article usage
Posted February 22, 2021.
IL-32 is a metabolic regulator promoting survival and proliferation of malignant plasma cells
Kristin Roseth Aass, Robin Mjelle, Martin H. Kastnes, Synne S. Tryggestad, Luca M. van den Brink, Marita Westhrin, Muhammad Zahoor, Siv H. Moen, Glenn Buene, Kristine Misund, Anne-Marit Sponaas, Qianli Ma, Anders Sundan, Richard WJ Groen, Tobias S. Slørdahl, Anders Waage, Therese Standal
bioRxiv 2021.02.22.431638; doi: https://doi.org/10.1101/2021.02.22.431638
IL-32 is a metabolic regulator promoting survival and proliferation of malignant plasma cells
Kristin Roseth Aass, Robin Mjelle, Martin H. Kastnes, Synne S. Tryggestad, Luca M. van den Brink, Marita Westhrin, Muhammad Zahoor, Siv H. Moen, Glenn Buene, Kristine Misund, Anne-Marit Sponaas, Qianli Ma, Anders Sundan, Richard WJ Groen, Tobias S. Slørdahl, Anders Waage, Therese Standal
bioRxiv 2021.02.22.431638; doi: https://doi.org/10.1101/2021.02.22.431638
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29129)
- Biophysics (14936)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60814)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)